Northwestern Medicine initiates Phase I trial of stem cells + cold virus for glioma

US-based advanced healthcare solutions provider Northwestern Medicine has initiated the Phase I trial of a new neural stem-cell therapy in combination with a common cold virus to detect and destroy brain cancer in patients with malignant glioma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news